Security key
500946108
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 12,801,623
- Total 13F value
- $144,841,768
- Share change
- +5,225,841
- Put/Call ratio
- 210%
- SEC-reported price per share
- $11.32
- Number of holders
- 98
- Value change
- +$60,140,705
- Number of buys
- 61
- Number of sells
- 33
- Shares outstanding
- 14,420,955
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
98
Top holders
10
KRRO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Previous quarter: Q3 2025
Korro Bio, Inc. SEC filings
Korro Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 500946108
Recent filing periods:
Ownership snapshot
Top reported holders of KRRO - Korro Bio, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lynx1 Capital Management LP
Disclosed value leader
Lynx1 Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 11%
13D/G row: Lynx1 Capital Management LP
Showing 1-6 of 15 holder rows.
Quick read
Lynx1 Capital Management LP leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lynx1 Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Lynx1 Capital Management LP
11%
Venrock Healthcare Capital Partne...
9.9%
New Enterprise Associates 17, L.P.
9.9%
Nantahala Capital Management, LLC
6.4%
CITADEL ADVISORS LLC
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP |
13D/G
13F
Company
|
11%
|
$18,351,871
1,538,296 shares
|
+$9,599,630 | 31 Mar 2026 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
9.9%
|
$17,760,012
1,488,685 shares
|
$0 | 10 Mar 2026 |
| New Enterprise Associates 17, L.P. |
13D/G
3/4/5
Ali Behbahani · 10%+ Owner
|
9.9%
|
$17,130,522
1,456,677 shares
|
$0 | 10 Mar 2026 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
6.4%
|
$5,394,000
600,000 shares
|
$0 | 31 Dec 2025 |
| CITADEL ADVISORS LLC |
13D/G
13F
Company
|
3.9%
|
$6,163,449
369,733 shares
|
$0 | 31 Dec 2024 |
| Deep Track Capital, LP |
13D/G
|
3%
|
$3,638,575
277,966 shares
|
$0 | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
98
Shares
12,801,623
Rows available
98
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q3 2025 Across Filers
Q3 2025 holders
90
Q1 2026 holders
98
Holder diff
8
| Investor | Q3 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend